PSU Profiles
Loading...
Keywords
Last Name
Institution

Jay Raman

TitleProfessor and Chief of Urology
InstitutionCollege of Medicine
DepartmentSurgery
Address500 University Drive Hershey PA 17033
vCardDownload vCard

    Collapse Biography 
    Collapse awards and honors
    2012 - 2013AUA Leadership Program, American Urological Association
    2015AUA Young Urologist of the Year, American Urological Association
    - 2015Surgeons as Leaders Program , American College of Surgeons (ACS)

    Collapse Overview 
    Collapse overview
    PREFERRED TITLE/ROLE:

    Physician, Professor

    EDUCATION:

    Fellowship, Urology, University of Texas Southwestern Medical Center (Dallas) (2008)
    Residency, Urology, New York and Presbyterian Hospital-Cornell Campus (2007)
    Residency, Surgery, General, New York and Presbyterian Hospital-Columbia Campus (2003)
    M.D., Cornell University Medical College (New York) (2001)

    RESEARCH INTERESTS:

    Urothelial carcinoma (Upper-tract and bladder)
    Kidney cancer
    Prostate cancer imaging
    Prevention of urologic infections
    Kidney ischemic injury
    Complications of urologic surgery
    Kidney tumor ablation
    Urinary stone disease



    REVIEWING ACTIVITIES::

    Canadian Journal of Urology, Editorial Board
    Journal of Urology
    European Urology Urology
    British Journal of Urology Journal of Endourology World Journal of Urology
    International Journal of Urology Expert Reviews in Anticancer Therapy Postgraduate Medicine
    The Scientific World





    CURRENT FUNDING:
    10/1/2014 – 12/1/2015
    Title: Exome sequencing of de novo bladder tumors detected at time of transurethral resection to determine molecular predictors of progression or response to intravesical therapy.
    Role: Co-PI

    (Raman) Ken and Bonnie Shockey Fund $50,000 7/1/2014 – 7/1/2016 Title: Development of a novel platform to identify and isolate prostate cancer circulating tumor cells for growth in a bone matrix.
    Role: Co-PI


    (Raman) $75,000 5/1/2013 – 5/1/2015
    Pacific Edge Biotechnologies
    Title: A Clinical, non-intervention study of the Cxbladder® urine test for the detection of recurrent urinary tract Urothelial Carcinoma (UC)
    Role: PI

    (Raman) $50,000 4/15/2013 – 4/15/2015
    Carefusion
    Title: Prospective evaluation of procedural povidone iodine rectal preparation (PIRP) to reduce infectious complications following ultrasound guided prostate needle biopsy.
    Role: PI


    COMPLETED RESEARCH SUPPORT:

    (Raman) $3,000 6/1/2013 – 10/1/2014
    Penn State Milton S. Hershey Medical Center Association of Friends and Family (AFF)
    Title: Longitudinal evaluation of urinary cancer incidence and outcomes over a 25-year period in the state of Pennsylvania
    Role: PI

    (Raman) $25,000 1/1/2012 – 12/31/2013
    Wells Fargo Barsumian Trust Grant
    Title: Prospective evaluation of a panel of urinary biomarkers to quantify kidney injury following shock wave lithotripsy (SWL).
    Role: PI

    (Raman) $20,000 9/1/2009 – 1/1/2013
    Penn State Milton S. Hershey Medical Center Department of Surgery Internal Funding
    Title: Prospective evaluation of urinary markers of kidney injury in patients undergoing partial and radical nephrectomy for renal cell carcinoma (RCC).
    Role: PI

    (Raman) $3,000 1/1/2011 – 1/1/2012 Penn State Milton S. Hershey Medical Center Association of Friends and Family (AFF)
    Title: Pilot investigation of urinary biomarker changes after surgical treatment of kidney stones.
    Role: PI

    (Raman)
    NCT00840294 $5,000 1/1/2009 – 1/1/2012
    Penn State Milton S. Hershey Medical Center Department of Surgery Internal Funding
    Title: Randomized Trial of Ciprofloxacin versus Observation for Men with Elevated Prostate Specific Antigen (PSA).
    Role: Co-PI


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kocher NJ, Jafri S, Balabhadra S, Lehman E, Gardner J, Vijay K, Sarwani N, Raman JD. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy? Urol Oncol. 2018 04; 36(4):156.e17-156.e22. PMID: 29276063.
      View in: PubMed
    2. Xia L, Pulido JE, Chelluri RR, Strother MC, Taylor BL, Raman JD, Guzzo TJ. Hospital volume and outcomes of robot-assisted partial nephrectomy. BJU Int. 2017 Dec 12. PMID: 29232025.
      View in: PubMed
    3. Park R, Rjepaj C, Lehman K, Raman JD. Comparison of two indices to annotate complications after radical nephroureterectomy. Can J Urol. 2017 Dec; 24(6):9103-9106. PMID: 29260635.
      View in: PubMed
    4. Qi DZ, Lehman K, Dewan K, Kirimanjeswara G, Raman JD. Preoperative urine culture is unnecessary in asymptomatic men prior to prostate needle biopsy. Int Urol Nephrol. 2018 Jan; 50(1):21-24. PMID: 29170899.
      View in: PubMed
    5. Singla N, Fang D, Su X, Bao Z, Cao Z, Robyak H, Xiong G, Zhang L, Woldu S, Hutchinson R, Sagalowsky A, Lotan Y, Li X, Zhou L, Raman JD, Margulis V. Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States. Urol Oncol. 2017 Nov 23. PMID: 29174945.
      View in: PubMed
    6. Syed JS, Nguyen KA, Suarez-Sarmiento A, Johnson K, Leapman MS, Raman JD, Shuch B. Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment. BJU Int. 2018 Jan; 121(1):124-129. PMID: 28972702.
      View in: PubMed
    7. Chipollini J, Abel EJ, Peyton CC, Boulware DC, Karam JA, Margulis V, Master VA, Zargar-Shoshtari K, Matin SF, Sexton WJ, Raman JD, Wood CG, Spiess PE. Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration. Clin Genitourin Cancer. 2017 Oct 17. PMID: 29113770.
      View in: PubMed
    8. Kocher NJ, Rjepaj C, Lehman E, Raman JD. Incidence and histologic features of mixed renal tumors. J Surg Oncol. 2017 Oct 16. PMID: 29044535.
      View in: PubMed
    9. Kocher NJ, Ilinsky D, Raman JD. Incarcerated Right Lateral Trocar-Site Hernia as a Rare Complication of Robot-Assisted Laparoscopic Prostatectomy. J Endourol Case Rep. 2017; 3(1):155-157. PMID: 29098201.
      View in: PubMed
    10. Wenger H, Razmaria A, Eggener S, Raman JD. Nerve Bundle Hydrodissection and Sexual Function after Robot Prostatectomy. JSLS. 2017 Oct-Dec; 21(4). PMID: 29279663.
      View in: PubMed
    11. Necchi A, Lo Vullo S, Mariani L, Moschini M, Hendricksen K, Rink M, Sosnowski R, Dobruch J, Raman JD, Wood CG, Margulis V, Roupret M, Briganti A, Montorsi F, Xylinas E, Shariat SF. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration. BJU Int. 2017 Sep 20. PMID: 28940605.
      View in: PubMed
    12. Raman JD. Author Reply. Urology. 2017 Dec; 110:43-44. PMID: 28935137.
      View in: PubMed
    13. Lin TR, Kocher NJ, Klausner AP, Raman JD. Longitudinal Gender Disparity in Female Urology Resident Primary Authorship at an American Urological Association Sectional Meeting. Urology. 2017 Dec; 110:40-44. PMID: 28842209.
      View in: PubMed
    14. Allen JL, Lehman K, Dewan K, Kirimanjeswara G, Raman JD. Procedural povidone iodine rectal preparation reduces bacteriuria and bacteremia following prostate needle biopsy. Can J Urol. 2017 Aug; 24(4):8883-8889. PMID: 28832305.
      View in: PubMed
    15. Warrick JI, Kaag M, Raman JD, Chan W, Tran T, Kunchala S, Shuman L, DeGraff D, Chen G. FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma. Virchows Arch. 2017 Jul 18. PMID: 28721490.
      View in: PubMed
    16. Rieken M, Shariat SF, Karam JA, Foerster B, Khani F, Gust K, Abufaraj M, Wood CG, Weizer AZ, Raman JD, Guo CC, Rioux-Leclercq N, Haitel A, Bensalah K, Lotan Y, Bachmann A, De Marzo AM, Robinson BD, Margulis V. Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy. J Urol. 2017 Dec; 198(6):1269-1277. PMID: 28709887.
      View in: PubMed
    17. Krabbe LM, Heitplatz B, Preuss S, Hutchinson RC, Woldu SL, Singla N, Boegemann M, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Rapoport LM, Glybochko PV, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Xylinas E, Margulis V. Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma. J Urol. 2017 Dec; 198(6):1253-1262. PMID: 28668287.
      View in: PubMed
    18. Raman JD, Park R. Endoscopic management of upper-tract urothelial carcinoma. Expert Rev Anticancer Ther. 2017 Jun; 17(6):545-554. PMID: 28480774.
      View in: PubMed
    19. Lotan Y, O'Sullivan P, Raman JD, Shariat SF, Kavalieris L, Frampton C, Guilford P, Luxmanan C, Suttie J, Crist H, Scherr D, Asroff S, Goldfischer E, Thill J, Darling D. Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma. Urol Oncol. 2017 Aug; 35(8):531.e15-531.e22. PMID: 28366272.
      View in: PubMed
    20. Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V, Stroup SP. An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy. J Urol. 2017 Aug; 198(2):329-334. PMID: 28363690.
      View in: PubMed
    21. Raman JD. Editorial Comment. Urology. 2017 04; 102:35-36. PMID: 28088435.
      View in: PubMed
    22. Kavalieris L, O'Sullivan P, Frampton C, Guilford P, Darling D, Jacobson E, Suttie J, Raman JD, Shariat SF, Lotan Y. Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study. J Urol. 2017 Jun; 197(6):1419-1426. PMID: 27986532.
      View in: PubMed
    23. Warrick JI, Walter V, Yamashita H, Chung E, Shuman L, Amponsa VO, Zheng Z, Chan W, Whitcomb TL, Yue F, Iyyanki T, Kawasawa YI, Kaag M, Guo W, Raman JD, Park JS, DeGraff DJ. FOXA1, GATA3 and PPAR? Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines. Sci Rep. 2016 Dec 07; 6:38531. PMID: 27924948.
      View in: PubMed
    24. Yamashita H, Amponsa VO, Warrick JI, Zheng Z, Clark PE, Raman JD, Wu XR, Mendelsohn C, DeGraff DJ. On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer. Nat Rev Urol. 2017 Feb; 14(2):98-106. PMID: 27898096.
      View in: PubMed
    25. Singla N, Fang D, Su X, Bao Z, Cao Z, Jafri SM, Xiong G, Zhang L, Hutchinson R, Sagalowsky A, Lotan Y, Li X, Zhou L, Raman JD, Margulis V. A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States. J Urol. 2017 May; 197(5):1208-1213. PMID: 27887951.
      View in: PubMed
    26. Lu DD, Boorjian SA, Raman JD. Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists. Urol Oncol. 2017 03; 35(3):113.e1-113.e7. PMID: 27884539.
      View in: PubMed
    27. Shah TS, Kaag M, Raman JD, Chan W, Tran T, Kunchala S, Shuman L, DeGraff DJ, Chen G, Warrick JI. Clinical significance of prominent retraction clefts in invasive urothelial carcinoma. Hum Pathol. 2017 03; 61:90-96. PMID: 27818288.
      View in: PubMed
    28. Wirth GJ, Haitel A, Moschini M, Soria F, Klatte T, Hassler MR, Bensalah K, Briganti A, Karam JA, Lotan Y, Margulis V, Raman JD, Remzi M, Rioux-Leclercq N, Robinson BD, Rouprêt M, Wood CG, Shariat SF. Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract. World J Urol. 2017 Jun; 35(6):943-949. PMID: 27730305.
      View in: PubMed
    29. Krabbe LM, Eminaga O, Shariat SF, Hutchinson RC, Lotan Y, Sagalowsky AI, Raman JD, Wood CG, Weizer AZ, Roscigno M, Montorsi F, Bolenz C, Novara G, Kikuchi E, Fajkovic H, Rapoport LM, Glybochko PV, Zigeuner R, Remzi M, Bensalah K, Kassouf W, Margulis V. Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma. J Urol. 2017 Mar; 197(3 Pt 1):580-589. PMID: 27670916.
      View in: PubMed
    30. Redrow GP, Guo CC, Brausi MA, Coleman JA, Fernandez MI, Kassouf W, Keeley FX, Margulis V, Raman JD, Roupret M, Shariat SF, Spiess PE, Thalmann GN, Matin SF. Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction. J Urol. 2017 Feb; 197(2):287-295. PMID: 27664578.
      View in: PubMed
    31. Lu DD, Raman JD. Strategies for prevention of ultrasound-guided prostate biopsy infections. Infect Drug Resist. 2016; 9:161-9. PMID: 27468242; PMCID: PMC4944912.
    32. Soria F, Moschini M, Haitel A, Wirth GJ, Karam JA, Wood CG, Rouprêt M, Margulis V, Karakiewicz PI, Briganti A, Raman JD, Kammerer-Jacquet SF, Mathieu R, Bensalah K, Lotan Y, Özsoy M, Remzi M, Gust KM, Shariat SF. HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC). World J Urol. 2017 Feb; 35(2):251-259. PMID: 27272502.
      View in: PubMed
    33. Vartolomei MD, Mathieu R, Margulis V, Karam JA, Rouprêt M, Lucca I, Mbeutcha A, Seitz C, Karakiewicz PI, Fajkovic H, Wood CG, Weizer AZ, Raman JD, Rioux-Leclercq N, Haitel A, Bensalah K, Rink M, Briganti A, Xylinas E, Shariat SF. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy. World J Urol. 2017 Jan; 35(1):121-130. PMID: 27209168.
      View in: PubMed
    34. Raman JD, Warrick JI, Caruso C, Yang Z, Shuman L, Bruggeman RD, Shariat S, Karam JA, Wood C, Weizer AZ, Remzi M, Haitel A, Bensalah K, Rioux-Leclerq N, Bolenz C, Roscigno M, Krabbe LM, Kapur P, Lotan Y, Margulis V, DeGraff DJ. Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract. Urology. 2016 Aug; 94:314.e1-7. PMID: 27215483.
      View in: PubMed
    35. Kocher NJ, Rjepaj C, Robyak H, Lehman E, Raman JD. Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer. World J Urol. 2017 Jan; 35(1):67-72. PMID: 27189620.
      View in: PubMed
    36. Raman JD, Reynolds C, Hannon M. An increasing proportion of perinephric to subcutaneous fat is associated with adverse perioperative outcomes of robotic partial nephrectomy. J Robot Surg. 2016 Sep; 10(3):255-9. PMID: 27160676.
      View in: PubMed
    37. Raman JD, Jafri SM, Qi D. Kidney function outcomes following thermal ablation of small renal masses. World J Nephrol. 2016 May 06; 5(3):283-7. PMID: 27152264; PMCID: PMC4848151.
    38. Raman JD, Jafri SM. Complications Following Radical Nephroureterectomy. Curr Urol Rep. 2016 May; 17(5):36. PMID: 26968416.
      View in: PubMed
    39. Favaretto RL, Bahadori A, Mathieu R, Haitel A, Grubmüller B, Margulis V, Karam JA, Rouprêt M, Seitz C, Karakiewicz PI, Cunha IW, Zequi SC, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Jacquet-Kammerer S, Bensalah K, Lotan Y, Bachmann A, Rink M, Briganti A, Shariat SF. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study. World J Urol. 2017 Jan; 35(1):113-120. PMID: 27129576.
      View in: PubMed
    40. Mbeutcha A, Rouprêt M, Kamat AM, Karakiewicz PI, Lawrentschuk N, Novara G, Raman JD, Seitz C, Xylinas E, Shariat SF. Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review. World J Urol. 2017 Mar; 35(3):337-353. PMID: 27101100.
      View in: PubMed
    41. Kaag MG, Raman JD. Clinical guidelines: Clearing murky water - a guideline-based approach to haematuria. Nat Rev Urol. 2016 May; 13(5):243-4. PMID: 27071454.
      View in: PubMed
    42. Raman JD. Kidney sparing surgery for upper-tract urothelial carcinoma. Minerva Urol Nefrol. 2016 Aug; 68(4):359-71. PMID: 27058053.
      View in: PubMed
    43. Regelman M, Raman JD. Robotic assisted laparoscopic repair of a symptomatic ureterosciatic hernia. Can J Urol. 2016 Apr; 23(2):8237-9. PMID: 27085830.
      View in: PubMed
    44. Warrick JI, Raman JD, Kaag M, Bruggeman T, Cates J, Clark P, DeGraff DJ. Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer. Urol Oncol. 2016 Jun; 34(6):258.e1-6. PMID: 26976725.
      View in: PubMed
    45. Raman JD. Editorial Comment. J Urol. 2016 Jun; 195(6):1683. PMID: 26945120.
      View in: PubMed
    46. Warrick JI, Kaag M, Raman JD, Chan W, Tran T, Kunchala S, DeGraff D, Chen G. Squamous Dysplasia of the Urinary Bladder: A Consecutive Cystectomy Series. Int J Surg Pathol. 2016 Jun; 24(4):306-14. PMID: 26860905.
      View in: PubMed
    47. Raman JD. Prognostic markers for urologic cancers. Can J Urol. 2016 Feb; 23(1):8155. PMID: 26892056.
      View in: PubMed
    48. Kocher NJ, Kunchala S, Reynolds C, Lehman E, Nie S, Raman JD. Adherent perinephric fat at minimally invasive partial nephrectomy is associated with adverse peri-operative outcomes and malignant renal histology. BJU Int. 2016 Apr; 117(4):636-41. PMID: 26573951.
      View in: PubMed
    49. Mbeutcha A, Lucca I, Margulis V, Karam JA, Wood CG, de Martino M, Mathieu R, Haitel A, Xylinas E, Kluth L, Rouprêt M, Karakiewicz PI, Briganti A, Rink M, Rieken M, Weizer AZ, Raman JD, Rioux-Leclecq N, Bolenz C, Bensalah K, Lotan Y, Seitz C, Remzi M, Shariat SF, Klatte T. Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent. World J Urol. 2016 Aug; 34(8):1155-61. PMID: 26658888.
      View in: PubMed
    50. Sobowale O, Riley K, Raman J, Harkins G. A Multi-Disciplinary Approach for the Surgical Management of Bladder Endometriosis. J Minim Invasive Gynecol. 2015 Nov-Dec; 22(6S):S130-S131. PMID: 27678706.
      View in: PubMed
    51. Blum RD, Raman JD. Significant methodologic variations in calculating renal function changes following kidney tumor surgery: A quality reporting issue? World J Clin Oncol. 2015 Oct 10; 6(5):89-91. PMID: 26468442; PMCID: PMC4600195.
    52. Ledezma RA, Negron E, Paner GP, Rjepaj C, Lascano D, Haseebuddin M, Dangle P, Shalhav AL, Crist H, Raman JD, Joel DeCastro G, Harik L, Paroder M, Uzzo RG, Kutikov A, Eggener SE. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. World J Urol. 2016 May; 34(5):687-93. PMID: 26407582.
      View in: PubMed
    53. Raman JD, Lehman KK, Dewan K, Kirimanjeswara G. Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection. J Vis Exp. 2015 Sep 21; (103). PMID: 26436913.
      View in: PubMed
    54. Raman JD, Taylor JA. Introduction for seminar series on urothelial carcinoma with squamous differentiation. Urol Oncol. 2015 Oct; 33(10):428. PMID: 26254012.
      View in: PubMed
    55. Mathieu R, Klatte T, Margulis V, Karam JA, Rouprêt M, Seitz C, Karakiewicz PI, Fajkovic H, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Bensalah K, Lotan Y, Rink M, Kluth LA, Scherr DS, Robinson BD, Shariat SF. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study. Urol Oncol. 2015 Nov; 33(11):495.e15-22. PMID: 26228160.
      View in: PubMed
    56. Raman JD, Jafri SM. Surgical management of bladder urothelial carcinoma with squamous differentiation. Urol Oncol. 2015 Oct; 33(10):429-33. PMID: 26206104.
      View in: PubMed
    57. Barbour ML, Raman JD. Incidence and Predictors for Ipsilateral Hydronephrosis Following Ureteroscopic Lithotripsy. Urology. 2015 Sep; 86(3):465-71. PMID: 26144338.
      View in: PubMed
    58. Raman JD. Volumetric changes following partial nephrectomy. Can J Urol. 2015 Jun; 22(3):7797. PMID: 26068627.
      View in: PubMed
    59. Raman JD, Rjepaj C, Otteni C. A single 80 mg intravenous gentamicin dose prior to prostate needle biopsy does not reduce procedural infectious complications. Cent European J Urol. 2015; 68(2):229-31. PMID: 26251751; PMCID: PMC4526609.
    60. Jafri SM, Raman JD. Systemic chemotherapy and radical nephroureterectomy. Int Urol Nephrol. 2015 May; 47(5):709-10. PMID: 25877406.
      View in: PubMed
    61. Raman JD. Hospital readmission following urologic surgery. Can J Urol. 2015 Feb; 22(1):7647. PMID: 25694013.
      View in: PubMed
    62. Raman JD. Considerations regarding active surveillance for small renal masses. Can J Urol. 2014 Dec; 21(6):7536. PMID: 25483760.
      View in: PubMed
    63. Krabbe LM, Bagrodia A, Haddad AQ, Kapur P, Khalil D, Hynan LS, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V. Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract. J Urol. 2015 May; 193(5):1486-93. PMID: 25451830.
      View in: PubMed
    64. Raman J, Hay P, Smith E. Manualised Cognitive Remediation Therapy for adult obesity: study protocol for a randomised controlled trial. Trials. 2014 Nov 04; 15:426. PMID: 25370364; PMCID: PMC4230366.
    65. Bagrodia A, Krabbe LM, Gayed BA, Kapur P, Bernstein I, Xie XJ, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclerq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V. Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma. Urology. 2014 Nov; 84(5):1134-40. PMID: 25443916.
      View in: PubMed
    66. Kaag M, Trost L, Thompson RH, Favaretto R, Elliott V, Shariat SF, Maschino A, Vertosick E, Raman JD, Dalbagni G. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int. 2014 Nov; 114(5):674-9. PMID: 24314050.
      View in: PubMed
    67. Haddad AQ, Kapur P, Singla N, Raman JD, Then MT, Nuhn P, Buchner A, Bastian P, Seitz C, Shariat SF, Bensalah K, Rioux-Leclercq N, Sagalowsky A, Lotan Y, Margulis V. Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma. Cancer. 2015 Jan 01; 121(1):43-50. PMID: 25186283.
      View in: PubMed
    68. Lin YK, Deliere A, Lehman K, Harpster LE, Kaag MG, Raman JD. Critical analysis of 30 day complications following radical nephroureterectomy for upper tract urothelial carcinoma. Can J Urol. 2014 Aug; 21(4):7369-73. PMID: 25171281.
      View in: PubMed
    69. Kaag MG, Raman JD. Editorial Comment from Dr Kaag and Dr Raman to Obesity and prognosis in muscle-invasive bladder cancer: the continuing controversy. Int J Urol. 2014 Nov; 21(11):1113. PMID: 25040684.
      View in: PubMed
    70. Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Ikeda M, Matsumoto K, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B, Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Rouprêt M, Tagawa ST, Chun FK, Scherr DS, Vickers AJ, Shariat SF. Predictors of survival in patients with disease recurrence after radical nephroureterectomy. BJU Int. 2014 Jun; 113(6):911-7. PMID: 24053651.
      View in: PubMed
    71. Reynolds C, Raman JD. Editorial comment. Urology. 2014 Aug; 84(2):284. PMID: 24837450.
      View in: PubMed
    72. Eggener SE, Clark MA, Shikanov S, Smith B, Kaag M, Russo P, Wheat JC, Wolf JS, Matin SF, Huang WC, Harel M, Cambio J, Shalhav AL, Raman JD. Impact of warm versus cold ischemia on renal function following partial nephrectomy. World J Urol. 2015 Mar; 33(3):351-7. PMID: 24817142.
      View in: PubMed
    73. Gyorfi JR, Otteni C, Brown K, Patel A, Lehman K, Phillips BE, Dewan K, Kirimanjeswara G, Raman JD. Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate. World J Urol. 2014 Aug; 32(4):905-9. PMID: 24682238.
      View in: PubMed
    74. Lin YK, Kaag M, Raman JD. Rationale and timing of perioperative chemotherapy for upper-tract urothelial carcinoma. Expert Rev Anticancer Ther. 2014 May; 14(5):543-51. PMID: 24666189.
      View in: PubMed
    75. Reynolds C, Hannon M, Lehman K, Harpster LE, Raman JD. An obese body habitus does not preclude a minimally invasive partial nephrectomy. Can J Urol. 2014 Feb; 21(1):7145-9. PMID: 24529018.
      View in: PubMed
    76. Lee DJ, Xylinas E, Rieken M, Khani F, Klatte T, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Guo CC, Rioux-Leclercq N, Haitel A, Bolenz C, Bensalah K, Sagalowsky AI, Montorsi F, Lotan Y, Shariat SF, Robinson BD, Margulis V. Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma. Eur Urol. 2014 Aug; 66(2):379-85. PMID: 24388440.
      View in: PubMed
    77. Raman JD, Lin YK, Kaag M, Atkinson T, Crispen P, Wille M, Smith N, Hockenberry M, Guzzo T, Peyronnet B, Bensalah K, Simhan J, Kutikov A, Cha E, Herman M, Scherr D, Shariat SF, Boorjian SA. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urol Oncol. 2014 Jan; 32(1):47.e9-14. PMID: 24140248.
      View in: PubMed
    78. Raman JD. Salvage ablation for partial nephrectomy failures. Can J Urol. 2013 Oct; 20(5):6938. PMID: 24128833.
      View in: PubMed
    79. Kapur P, Christie A, Raman JD, Then MT, Nuhn P, Buchner A, Bastian P, Seitz C, Shariat SF, Bensalah K, Rioux-Leclercq N, Xie XJ, Lotan Y, Margulis V, Brugarolas J. BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma. J Urol. 2014 Mar; 191(3):603-10. PMID: 24076305.
      View in: PubMed
    80. Xylinas E, Kluth L, Passoni N, Trinh QD, Rieken M, Lee RK, Fajkovic H, Novara G, Margulis V, Raman JD, Lotan Y, Rouprêt M, Aziz A, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Walton T, Karakiewicz PI, Montorsi F, Zerbib M, Scherr DS, Shariat SF. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol. 2014 Mar; 65(3):650-8. PMID: 24070577.
      View in: PubMed
    81. Youssef RF, Lotan Y, Sagalowsky AI, Shariat SF, Wood CG, Raman JD, Langner C, Zigeuner R, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V. Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy? Int Braz J Urol. 2013 Sep-Oct; 39(5):614-21. PMID: 24267122.
      View in: PubMed
    82. Eggener SE, Large MC, Gerber GS, Pettus J, Yossepowitch O, Smith ND, Kundu S, Kunnavakkam R, Zorn K, Raman JD. Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial. BJU Int. 2013 Nov; 112(7):925-9. PMID: 23890317.
      View in: PubMed
    83. Raman JD. Infectious complications following prostate biopsy: a problem with need for solution. Can J Urol. 2013 Jun; 20(3):6815. PMID: 23783055.
      View in: PubMed
    84. Smith P, Mandel J, Raman JD. Conservative nephron-sparing treatment of upper-tract tumors. Curr Urol Rep. 2013 Apr; 14(2):102-8. PMID: 23344683.
      View in: PubMed
    85. Raman JD. Percutaneous renal biopsy may aid management of small renal masses on active surveillance. Can J Urol. 2013 Apr; 20(2):6742. PMID: 23587519.
      View in: PubMed
    86. Lin YK, Raman JD. Small renal masses: is LESS partial nephrectomy feasible for most urologists? Nat Rev Urol. 2013 May; 10(5):260-1. PMID: 23528700.
      View in: PubMed
    87. Bagrodia A, Kuehhas FE, Gayed BA, Wood CG, Raman JD, Kapur P, Derweesh IH, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma. Urology. 2013 May; 81(5):972-7. PMID: 23523292.
      View in: PubMed
    88. Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E, Novara G, Raman JD, Lotan Y, Weizer A, Roupret M, Pycha A, Scherr DS, Seitz C, Ficarra V, Trinh QD, Karakiewicz PI, Montorsi F, Zerbib M, Shariat SF. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int. 2013 Aug; 112(4):453-61. PMID: 23464979.
      View in: PubMed
    89. Rink M, Xylinas E, Trinh QD, Lotan Y, Margulis V, Raman JD, Fisch M, Lee RK, Chun FK, Abdennabi J, Seitz C, Pycha A, Zlotta AR, Karakiewicz PI, Babjuk M, Scherr DS, Shariat SF. Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes. BJU Int. 2013 Sep; 112(5):623-37. PMID: 23465088.
      View in: PubMed
    90. Lin YK, Gettle L, Raman JD. Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols? BJU Int. 2013 May; 111(6):891-6. PMID: 23331317.
      View in: PubMed
    91. Xylinas E, Rink M, Margulis V, Faison T, Comploj E, Novara G, Raman JD, Lotan Y, Guillonneau B, Weizer A, Pycha A, Scherr DS, Seitz C, Sun M, Trinh QD, Karakiewicz PI, Montorsi F, Zerbib M, Gönen M, Shariat SF. Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy. J Urol. 2013 Feb; 189(2):468-73. PMID: 23253960.
      View in: PubMed
    92. Palmerola R, Smith P, Elliot V, Reese CT, Mahon FB, Harpster LE, Icitovic N, Raman JD. The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy. Can J Urol. 2012 Dec; 19(6):6542-7. PMID: 23228289.
      View in: PubMed
    93. Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol. 2013 May; 189(5):1662-9. PMID: 23103802.
      View in: PubMed
    94. Rippel CA, Nikkel L, Lin YK, Danawala Z, Olorunnisomo V, Youssef RF, Pearle MS, Lotan Y, Raman JD. Residual fragments following ureteroscopic lithotripsy: incidence and predictors on postoperative computerized tomography. J Urol. 2012 Dec; 188(6):2246-51. PMID: 23083650.
      View in: PubMed
    95. Smith PH, Elliott VL, Raman JD. Contemporary management of small renal masses: does practice environment matter? Can J Urol. 2012 Oct; 19(5):6438-42. PMID: 23040625.
      View in: PubMed
    96. Fajkovic H, Cha EK, Xylinas E, Rink M, Pycha A, Seitz C, Bolenz C, Dunning A, Novara G, Trinh QD, Karakiewicz PI, Margulis V, Raman JD, Walton TJ, Baba S, Carballido J, Otto W, Montorsi F, Lotan Y, Kassouf W, Fritsche HM, Bensalah K, Zigeuner R, Scherr DS, Sonpavde G, Roupret M, Shariat SF. Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma. World J Urol. 2013 Feb; 31(1):5-11. PMID: 23011256.
      View in: PubMed
    97. Raman JD. Editorial Comment to renal pelvic villous adenoma presented with mucusuria: report of a case and literature review. Int J Urol. 2013 Feb; 20(2):250. PMID: 22994387.
      View in: PubMed
    98. Rink M, Sjoberg D, Comploj E, Margulis V, Xylinas E, Lee RK, Hansen J, Cha EK, Raman JD, Remzi M, Bensalah K, Novara G, Matin SF, Chun FK, Kikuchi E, Kassouf W, Martinez-Salamanca JI, Lotan Y, Seitz C, Pycha A, Zigeuner R, Karakiewicz PI, Scherr DS, Vickers AJ, Shariat SF. Risk of cancer-specific mortality following recurrence after radical nephroureterectomy. Ann Surg Oncol. 2012 Dec; 19(13):4337-44. PMID: 22805867; PMCID: PMC3576920.
    99. Rink M, Xylinas E, Margulis V, Cha EK, Ehdaie B, Raman JD, Chun FK, Matsumoto K, Lotan Y, Furberg H, Babjuk M, Pycha A, Wood CG, Karakiewicz PI, Fisch M, Scherr DS, Shariat SF. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol. 2013 Jun; 63(6):1082-90. PMID: 22743166; PMCID: PMC3969987.
    100. Rink M, Robinson BD, Green DA, Cha EK, Hansen J, Comploj E, Margulis V, Raman JD, Ng CK, Remzi M, Bensalah K, Kabbani W, Haitel A, Rioux-Leclercq N, Guo CC, Chun FK, Kikuchi E, Kassouf W, Sircar K, Sun M, Sonpavde G, Lotan Y, Pycha A, Karakiewicz PI, Scherr DS, Shariat SF. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol. 2012 Aug; 188(2):398-404. PMID: 22698626.
      View in: PubMed
    101. Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2014 Jan; 65(1):210-7. PMID: 22579047.
      View in: PubMed
    102. Clements T, Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, Scoll B, Boorjian SA, Uzzo RG, Wille M, Eggener SE, Lucas SM, Lotan Y, Shariat SF, Raman JD. High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol. 2012 Apr; 26(4):398-402. PMID: 22192113.
      View in: PubMed
    103. Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, Margulis V, Raman JD, Svatek RS, Fajkovic H, Lee RK, Novara G, Hansen J, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Fisch M, Scherr DS, Shariat SF. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol. 2012 Oct; 62(4):677-84. PMID: 22349570.
      View in: PubMed
    104. Pinkhasov GI, Lin YK, Palmerola R, Smith P, Mahon F, Kaag MG, Dagen JE, Harpster LE, Reese CT, Raman JD. Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases. BJU Int. 2012 Aug; 110(3):369-74. PMID: 22313996.
      View in: PubMed
    105. Shariat SF, Zigeuner R, Rink M, Margulis V, Hansen J, Kikuchi E, Kassouf W, Raman JD, Remzi M, Koppie TM, Bensalah K, Guo CC, Mikami S, Sircar K, Ng CK, Haitel A, Kabbani W, Chun FK, Wood CG, Scherr DS, Karakiewicz PI, Langner C. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. Eur Urol. 2012 Aug; 62(2):224-31. PMID: 22285763.
      View in: PubMed
    106. Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2012 Apr; 61(4):818-25. PMID: 22284969.
      View in: PubMed
    107. Fajkovic H, Cha EK, Jeldres C, Donner G, Chromecki TF, Margulis V, Novara G, Lotan Y, Raman JD, Kassouf W, Seitz C, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Breinl E, Pycha A, Ficarra V, Montorsi F, Karakiewicz PI, Scherr DS, Shariat SF. Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. J Urol. 2012 Mar; 187(3):845-51. PMID: 22248522.
      View in: PubMed
    108. Clements T, Raman JD. Surgery: is perinephric drainage essential after partial nephrectomy? Nat Rev Urol. 2011 10 18; 8(11):594-5. PMID: 22009416.
      View in: PubMed
    109. Hollenbeak CS, Nikkel LE, Schaefer EW, Alemao E, Ghahramani N, Raman JD. Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma. J Manag Care Pharm. 2011 Oct; 17(8):610-20. PMID: 21942302; PMCID: PMC3350946.
    110. Raman JD, Smith B, Messer J, Rohner TJ, Harpster LE, Reese CT. Preoperative predictors of surgical approach for partial nephrectomy. Can J Urol. 2011 Oct; 18(5):5896-902. PMID: 22018152.
      View in: PubMed
    111. Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol. 2012 Feb; 61(2):245-53. PMID: 21975249.
      View in: PubMed
    112. Raman JD. Editorial comment. J Urol. 2011 Nov; 186(5):1848. PMID: 21944986.
      View in: PubMed
    113. Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, Scoll B, Boorjian SA, Uzzo RG, Wille M, Eggener SE, Lucas SM, Lotan Y, Shariat SF, Raman JD. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. Urol Oncol. 2013 Aug; 31(6):904-8. PMID: 21906967.
      View in: PubMed
    114. Verhoest G, Shariat SF, Chromecki TF, Raman JD, Margulis V, Novara G, Seitz C, Remzi M, Rouprêt M, Scherr DS, Bensalah K. Predictive factors of recurrence and survival of upper tract urothelial carcinomas. World J Urol. 2011 Aug; 29(4):495-501. PMID: 21681525; PMCID: PMC3526475.
    115. Lin YK, Gettle L, Raman JD. Variable prostate-specific antigen management patterns by nonurologist providers at a tertiary care medical center. Urology. 2011 Aug; 78(2):244-8. PMID: 21664655.
      View in: PubMed
    116. Clements T, Lin YK, Raman JD. Current status of ablative techniques for small renal masses. Expert Rev Anticancer Ther. 2011 Jun; 11(6):879-91. PMID: 21707285.
      View in: PubMed
    117. Clements T, Raman JD. Laparoendoscopic single-site pyeloplasty. Ther Adv Urol. 2011 Jun; 3(3):141-9. PMID: 21904570; PMCID: PMC3159399.
    118. Messer J, Lin YK, Raman JD. The role of lymphadenectomy for upper tract urothelial carcinoma. Nat Rev Urol. 2011 May 24; 8(7):394-401. PMID: 21606972.
      View in: PubMed
    119. Ehdaie B, Chromecki TF, Lee RK, Lotan Y, Margulis V, Karakiewicz PI, Novara G, Raman JD, Ng C, Lowrance WT, Scherr DS, Shariat SF. Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol. 2011 Jul; 186(1):66-72. PMID: 21571333; PMCID: PMC4170670.
    120. Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M, Shariat SF. Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int. 2011 Oct; 108(8 Pt 2):E304-9. PMID: 21507184.
      View in: PubMed
    121. Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martínez-Salamanca JI, Scherr DS, Shariat SF. Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol. 2011 Aug; 29(4):473-80. PMID: 21499902.
      View in: PubMed
    122. Best SL, Donnally C, Mir SA, Tracy CR, Raman JD, Cadeddu JA. Complications during the initial experience with laparoendoscopic single-site pyeloplasty. BJU Int. 2011 Oct; 108(8):1326-9. PMID: 21410632.
      View in: PubMed
    123. Gurbuz C, Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. J Endourol. 2011 May; 25(5):775-9. PMID: 21388245.
      View in: PubMed
    124. Raman JD. Editorial comment. The natural history of renal stone fragments following ureteroscopy. Urology. 2011 Mar; 77(3):568-9. PMID: 21377005.
      View in: PubMed
    125. Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Kabbani W, Langner C, Guo CC, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. BJU Int. 2011 Oct; 108(8):1286-91. PMID: 21332905.
      View in: PubMed
    126. Messer J, Shariat SF, Brien JC, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Steinberg G, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int. 2011 Sep; 108(5):701-5. PMID: 21320275.
      View in: PubMed
    127. Elliott VL, Smith PH, Raman JD. Are urology residents adequately exposed to conservative therapies for managing small renal masses? J Endourol. 2011 Jan; 25(1):129-33. PMID: 21247292.
      View in: PubMed
    128. Clark MA, Shikanov S, Raman JD, Smith B, Kaag M, Russo P, Wheat JC, Wolf JS, Matin SF, Huang WC, Shalhav AL, Eggener SE. Chronic kidney disease before and after partial nephrectomy. J Urol. 2011 Jan; 185(1):43-8. PMID: 21074205.
      View in: PubMed
    129. Mir SA, Best SL, Donnally CJ, Gurbuz C, Tracy CR, Raman JD, Cadeddu JA. Minimally invasive nephrectomy: the influence of laparoendoscopic single-site surgery on patient selection, outcomes, and morbidity. Urology. 2011 Mar; 77(3):631-4. PMID: 21067800.
      View in: PubMed
    130. Shikanov S, Clark MA, Raman JD, Smith B, Kaag M, Russo P, Wheat JC, Wolf JS, Huang WC, Shalhav AL, Eggener SE. Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy. J Urol. 2010 Nov; 184(5):1867-71. PMID: 20846677.
      View in: PubMed
    131. Raman JD, Messer J, Sielatycki JA, Hollenbeak CS. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. BJU Int. 2011 Apr; 107(7):1059-64. PMID: 20825397.
      View in: PubMed
    132. Tappouni R, El-Kady R, Raman J, Then M, Sarwani N. Renal neuroectodermal tumour presenting with hematuria. J Radiol Case Rep. 2010; 4(7):12-20. PMID: 22470742; PMCID: PMC3303359.
    133. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer. 2010 Jul 01; 116(13):3135-42. PMID: 20564644.
      View in: PubMed
    134. Kaag MG, O'Malley RL, O'Malley P, Godoy G, Chen M, Smaldone MC, Hrebinko RL, Raman JD, Bochner B, Dalbagni G, Stifelman MD, Taneja SS, Huang WC. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol. 2010 Oct; 58(4):581-7. PMID: 20619530; PMCID: PMC3677959.
    135. Margulis V, Youssef RF, Karakiewicz PI, Lotan Y, Wood CG, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Shariat SF. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol. 2010 Aug; 184(2):453-8. PMID: 20620397.
      View in: PubMed
    136. Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol. 2010 Jul; 184(1):69-73. PMID: 20478585.
      View in: PubMed
    137. Wheat JC, Weizer AZ, Wolf JS, Lotan Y, Remzi M, Margulis V, Wood CG, Montorsi F, Roscigno M, Kikuchi E, Zigeuner R, Langner C, Bolenz C, Koppie TM, Raman JD, Fernández M, Karakiewizc P, Capitanio U, Bensalah K, Patard JJ, Shariat SF. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol. 2012 May-Jun; 30(3):252-8. PMID: 20451416.
      View in: PubMed
    138. Raman JD. Editorial comment. Urology. 2010 May; 75(5):1046; author reply 1047. PMID: 20451712.
      View in: PubMed
    139. Igor Pinkhasov G, Raman JD. Management and prevention of renal ablative therapy complications. World J Urol. 2010 Oct; 28(5):559-64. PMID: 20383639.
      View in: PubMed
    140. Hall DW, Raman JD. Has laparoscopy impacted the indications for adrenalectomy? Curr Urol Rep. 2010 Mar; 11(2):132-7. PMID: 20425102.
      View in: PubMed
    141. Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M, Montorsi F, Bolenz C, Weizer AZ, Wheat JC, Ng CK, Scherr DS, Remzi M, Waldert M, Wood CG, Margulis V. Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol. 2011 Nov-Dec; 29(6):716-23. PMID: 20056458.
      View in: PubMed
    142. Raman JD, Bagrodia A, Bensalah K, Pearle MS, Lotan Y. Residual fragments after percutaneous nephrolithotomy: cost comparison of immediate second look flexible nephroscopy versus expectant management. J Urol. 2010 Jan; 183(1):188-93. PMID: 19913809.
      View in: PubMed
    143. Raman JD, Hall DW, Cadeddu JA. Renal ablative therapy: radiofrequency ablation and cryoablation. J Surg Oncol. 2009 Dec 15; 100(8):639-44. PMID: 20017159.
      View in: PubMed
    144. Zigeuner R, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Weizer A, Kikuchi E, Remzi M, Raman JD, Bolenz C, Bensalah K, Capitanio U, Koppie TM, Kassouf W, Sircar K, Patard JJ, Fernández MI, Wood CG, Montorsi F, Ströbel P, Wheat JC, Haitel A, Oya M, Guo CC, Ng C, Chade DC, Sagalowsky A, Langner C. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol. 2010 Apr; 57(4):575-81. PMID: 19959276.
      View in: PubMed
    145. Kutikov A, Uzzo RG, Caraway A, Reese CT, Egleston BL, Chen DY, Viterbo R, Greenberg RE, Wong YN, Raman JD, Boorjian SA. Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. BJU Int. 2010 Jul; 106(2):218-23. PMID: 19922542; PMCID: PMC2906619.
    146. Shariat SF, Godoy G, Lotan Y, Droller M, Karakiewicz PI, Raman JD, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Wheat JC, Zigeuner R, Langner C, Wood CG, Margulis V. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int. 2010 Jun; 105(12):1672-7. PMID: 19912201.
      View in: PubMed
    147. Winter C, Raman JD, Sheinfeld J, Albers P. Retroperitoneal lymph node dissection after chemotherapy. BJU Int. 2009 Nov; 104(9 Pt B):1404-12. PMID: 19840021.
      View in: PubMed
    148. Waldert M, Karakiewicz PI, Raman JD, Remzi M, Isbarn H, Lotan Y, Capitanio U, Bensalah K, Marberger MJ, Shariat SF. A delay in radical nephroureterectomy can lead to upstaging. BJU Int. 2010 Mar; 105(6):812-7. PMID: 19732052.
      View in: PubMed
    149. Raman JD, Raj GV, Lucas SM, Williams SK, Lauer EM, Ahrar K, Matin SF, Leveillee RJ, Cadeddu JA. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int. 2010 Feb; 105(4):496-500. PMID: 19681900.
      View in: PubMed
    150. Tracy CR, Raman JD, Bagrodia A, Cadeddu JA. Perioperative outcomes in patients undergoing conventional laparoscopic versus laparoendoscopic single-site pyeloplasty. Urology. 2009 Nov; 74(5):1029-34. PMID: 19660793.
      View in: PubMed
    151. Raman JD, Bensalah K, Bagrodia A, Tracy CR, Kabbani W, Sagalowsky AI, Cadeddu JA. Comparison of tissue oxygenation profiles using 3 different methods of vascular control during porcine partial nephrectomy. Urology. 2009 Oct; 74(4):926-31. PMID: 19628267.
      View in: PubMed
    152. Bensalah K, Tuncel A, Raman JD, Bagrodia A, Pearle M, Lotan Y. How physician and patient perceptions differ regarding medical management of stone disease. J Urol. 2009 Sep; 182(3):998-1004. PMID: 19616801.
      View in: PubMed
    153. Hellenthal NJ, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Bolenz C, Remzi M, Weizer A, Zigeuner R, Bensalah K, Ng CK, Raman JD, Kikuchi E, Montorsi F, Oya M, Wood CG, Fernandez M, Evans CP, Koppie TM. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol. 2009 Sep; 182(3):900-6. PMID: 19616245.
      View in: PubMed
    154. Raman JD, Ng CK, Scherr DS, Margulis V, Lotan Y, Bensalah K, Patard JJ, Kikuchi E, Montorsi F, Zigeuner R, Weizer A, Bolenz C, Koppie TM, Isbarn H, Jeldres C, Kabbani W, Remzi M, Waldert M, Wood CG, Roscigno M, Oya M, Langner C, Wolf JS, Ströbel P, Fernández M, Karakiewcz P, Shariat SF. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol. 2010 Jun; 57(6):1072-9. PMID: 19619934.
      View in: PubMed
    155. Gupta A, Raman JD, Leveillee RJ, Wingo MS, Zeltser IS, Lotan Y, Trimmer C, Stern JM, Cadeddu JA. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol. 2009 Jul; 23(7):1099-105. PMID: 19530948.
      View in: PubMed
    156. Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Zigeuner R, Weizer A, Sagalowsky A, Bensalah K, Raman JD, Bolenz C, Kassou W, Koppie TM, Wood CG, Wheat J, Langner C, Ng CK, Capitanio U, Bertini R, Fernández MI, Mikami S, Isida M, Ströbel P, Montorsi F. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol. 2009 Sep; 56(3):512-8. PMID: 19559518.
      View in: PubMed
    157. Bagrodia A, Gupta A, Raman JD, Bensalah K, Pearle MS, Lotan Y. Predictors of cost and clinical outcomes of percutaneous nephrostolithotomy. J Urol. 2009 Aug; 182(2):586-90. PMID: 19535106.
      View in: PubMed
    158. Bensalah K, Raman JD, Zeltser IS, Bagrodia A, Lucas SM, Kabbani W, Cadeddu JA. A comparison of kidney oxygenation profiles between partial and complete renal artery clamping during nephron sparing surgery in a porcine model. Can J Urol. 2009 Jun; 16(3):4632-8. PMID: 19497169.
      View in: PubMed
    159. Eggener SE, Raman JD. Re: Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen. S. Baltaci, E. Suer, A. H. Haliloglu, M. I. Gokce, A. H. Elhan and Y. Beduk. J Urol 2009; 181: 128-132. J Urol. 2009 Jul; 182(1):396-7. PMID: 19467675.
      View in: PubMed
    160. Raman JD, Scott DJ, Cadeddu JA. Role of magnetic anchors during laparoendoscopic single site surgery and NOTES. J Endourol. 2009 May; 23(5):781-6. PMID: 19397426.
      View in: PubMed
    161. Brien JC, Raman JD. Editorial comment. Urology. 2009 May; 73(5):1065-6; author reply 1066. PMID: 19394505.
      View in: PubMed
    162. Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman JD, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J, Kabbani W, Koppie TM, Ng CK, Suardi N, Bertini R, Fernández MI, Mikami S, Isida M, Michel MS, Montorsi F. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol. 2009 Jun; 181(6):2482-9. PMID: 19371878.
      View in: PubMed
    163. Stern JM, Gupta A, Raman JD, Cost N, Lucas S, Lotan Y, Raj GV, Cadeddu JA. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome. BJU Int. 2009 Sep; 104(6):786-9. PMID: 19426196.
      View in: PubMed
    164. Capitanio U, Shariat SF, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Raman JD, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Fernández MI, Ströbel P, Wheat J, Zigeuner R, Langner C, Waldert M, Oya M, Guo CC, Ng C, Montorsi F, Wood CG, Margulis V, Karakiewicz PI. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol. 2009 Jul; 56(1):1-9. PMID: 19361911.
      View in: PubMed
    165. Rosoff JS, Raman JD, Sosa RE, Del Pizzo JJ. Laparoscopic radical nephrectomy for renal masses 7 centimeters or larger. JSLS. 2009 Apr-Jun; 13(2):148-53. PMID: 19660207; PMCID: PMC3015927.
    166. Bagrodia A, Raman JD. Ergonomics considerations of radical prostatectomy: physician perspective of open, laparoscopic, and robot-assisted techniques. J Endourol. 2009 Apr; 23(4):627-33. PMID: 19358686.
      View in: PubMed
    167. Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009 Mar 15; 115(6):1224-33. PMID: 19156917.
      View in: PubMed
    168. Raman JD, Bergs RA, Fernandez R, Bagrodia A, Scott DJ, Tang SJ, Pearle MS, Cadeddu JA. Complete transvaginal NOTES nephrectomy using magnetically anchored instrumentation. J Endourol. 2009 Mar; 23(3):367-71. PMID: 19196056.
      View in: PubMed
    169. Gimenez SE, Secasan C, Raman JD. Prognostic markers and targeted therapies for renal cell carcinoma. Future Oncol. 2009 Mar; 5(2):197-205. PMID: 19284378.
      View in: PubMed
    170. Carraway WA, Raman JD, Cadeddu JA. Current status of renal radiofrequency ablation. Curr Opin Urol. 2009 Mar; 19(2):143-7. PMID: 19188768.
      View in: PubMed
    171. Raman JD, Bagrodia A, Gupta A, Bensalah K, Cadeddu JA, Lotan Y, Pearle MS. Natural history of residual fragments following percutaneous nephrostolithotomy. J Urol. 2009 Mar; 181(3):1163-8. PMID: 19152935.
      View in: PubMed
    172. Lauer E, Del Pizzo JJ, Raman JD. Needlescopic ablation of small adrenal masses. Curr Urol Rep. 2009 Jan; 10(1):73-7. PMID: 19116099.
      View in: PubMed
    173. Ng CK, Shariat SF, Lucas SM, Bagrodia A, Lotan Y, Scherr DS, Raman JD. Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? Urol Oncol. 2011 Jan-Feb; 29(1):27-32. PMID: 19117771.
      View in: PubMed
    174. Kikuchi E, Margulis V, Karakiewicz PI, Roscigno M, Mikami S, Lotan Y, Remzi M, Bolenz C, Langner C, Weizer A, Montorsi F, Bensalah K, Koppie TM, Fernández MI, Raman JD, Kassouf W, Wood CG, Suardi N, Oya M, Shariat SF. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2009 Feb 01; 27(4):612-8. PMID: 19075275; PMCID: PMC2737380.
    175. Raman JD. Re: Single port transumbilical (E-NOTES) donor nephrectomy: I. S. Gill, D. Canes, M. Aron, G.-P. Haber, D. A. Goldfarb, S. Flechner, M. R. Desai, J. H. Kaouk and M. M. Desai J Urol 2008; 180: 637-641. J Urol. 2009 Jan; 181(1):418-9; author reply 419. PMID: 19019385.
      View in: PubMed
    176. Cadeddu JA, Raman JD. Renal tumor ablation is a function of patient selection and technique--not the ablation technology. Cancer. 2008 Nov 15; 113(10):2623-6. PMID: 18816609.
      View in: PubMed
    177. Bagrodia A, Raman JD, Bensalah K, Pearle MS, Lotan Y. Synchronous bilateral percutaneous nephrostolithotomy: analysis of clinical outcomes, cost and surgeon reimbursement. J Urol. 2009 Jan; 181(1):149-53. PMID: 19012904.
      View in: PubMed
    178. Bolenz C, Shariat SF, Fernández MI, Margulis V, Lotan Y, Karakiewicz P, Remzi M, Kikuchi E, Zigeuner R, Weizer A, Montorsi F, Bensalah K, Wood CG, Roscigno M, Langner C, Koppie TM, Raman JD, Mikami S, Michel MS, Ströbel P. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int. 2009 Feb; 103(3):302-6. PMID: 18990164.
      View in: PubMed
    179. Remzi M, Haitel A, Margulis V, Karakiewicz P, Karakiewizc P, Montorsi F, Kikuchi E, Zigeuner R, Weizer A, Bolenz C, Bensalah K, Suardi N, Raman JD, Lotan Y, Waldert M, Ng CK, Fernández M, Koppie TM, Ströbel P, Kabbani W, Murai M, Langner C, Roscigno M, Wheat J, Guo CC, Wood CG, Shariat SF. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int. 2009 Feb; 103(3):307-11. PMID: 18990163.
      View in: PubMed
    180. Fernández MI, Shariat SF, Margulis V, Bolenz C, Montorsi F, Suardi N, Remzi M, Wood CG, Roscigno M, Kikuchi E, Oya M, Zigeuner R, Langner C, Weizer A, Lotan Y, Koppie TM, Raman JD, Karakiewicz P, Karakiewizc P, Bensalah K, Schultz M, Bernier P. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology. 2009 Jan; 73(1):142-6. PMID: 18845322.
      View in: PubMed
    181. Bensalah K, Peswani D, Tuncel A, Raman JD, Zeltser I, Liu H, Cadeddu J. Optical reflectance spectroscopy to differentiate benign from malignant renal tumors at surgery. Urology. 2009 Jan; 73(1):178-81. PMID: 18845323.
      View in: PubMed
    182. Raman JD, Sooriakumaran P, Cadeddu JA, Rane A. Radical and non-radical nephrectomy: no place for 'simple'. BJU Int. 2009 Apr; 103(7):855-6. PMID: 18990167.
      View in: PubMed
    183. Tracy CR, Raman JD, Cadeddu JA, Rane A. Laparoendoscopic single-site surgery in urology: where have we been and where are we heading? Nat Clin Pract Urol. 2008 Oct; 5(10):561-8. PMID: 18836465.
      View in: PubMed
    184. Raman JD, Cadeddu JA. Single access laparoscopic nephrectomy. Indian J Urol. 2008 Oct; 24(4):457-60. PMID: 19468496; PMCID: PMC2684410.
    185. Bagrodia A, Gupta A, Raman JD, Bensalah K, Pearle MS, Lotan Y. Impact of body mass index on cost and clinical outcomes after percutaneous nephrostolithotomy. Urology. 2008 Oct; 72(4):756-60. PMID: 18718645.
      View in: PubMed
    186. Raman JD, Ng CK, Shariat SF, Margulis V, Montorsi F, Karakiewicz P. Outcomes for patients with pT0 disease after radical nephroureterectomy for upper-tract urothelial carcinoma. BJU Int. 2009 Jan; 103(1):3-4. PMID: 18717670.
      View in: PubMed
    187. Raman JD, Cadeddu JA. Re: Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review D. A. Kunkle, B. L. Egleston and R. G. Uzzo J Urol 2008; 179: 1227-1234. J Urol. 2008 Oct; 180(4):1567-8; author reply 1568. PMID: 18710769.
      View in: PubMed
    188. Raman JD, Bagrodia A, Cadeddu JA. Single-incision, umbilical laparoscopic versus conventional laparoscopic nephrectomy: a comparison of perioperative outcomes and short-term measures of convalescence. Eur Urol. 2009 May; 55(5):1198-204. PMID: 18715694.
      View in: PubMed
    189. Gimenez E, Raman JD, Lieberman M, Vaughan ED. Cutaneous renocolic fistula associated with diverticulitis. Can J Urol. 2008 Aug; 15(4):4191-3. PMID: 18706151.
      View in: PubMed
    190. Raman JD. Re: Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract. E. Comperat, M. Roupret, E. Chartier-Kastler, M. O. Bitker, F. Richard, P. Camparo, F. Capron and O. Cussenot. J Urol 2008; 179: 868-872. J Urol. 2008 Sep; 180(3):1183; author reply 1183-4. PMID: 18639275.
      View in: PubMed
    191. Bernal F, Raman JD. Exploration of treatment options for the management of stage I testicular seminoma. Expert Rev Anticancer Ther. 2008 Jul; 8(7):1081-90. PMID: 18588453.
      View in: PubMed
    192. Raman JD, Stern JM, Zeltser I, Kabbani W, Cadeddu JA. Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging. J Urol. 2008 Jun; 179(6):2142-5. PMID: 18423723.
      View in: PubMed
    193. Bensalah K, Tuncel A, Gupta A, Raman JD, Pearle MS, Lotan Y. Determinants of quality of life for patients with kidney stones. J Urol. 2008 Jun; 179(6):2238-43; discussion 2243. PMID: 18423704.
      View in: PubMed
    194. Stern JM, Merritt ME, Zeltser I, Raman JD, Cadeddu JA. Phase one pilot study using magnetic resonance spectroscopy to predict the histology of radiofrequency-ablated renal tissue. Eur Urol. 2009 Feb; 55(2):433-8. PMID: 18423968.
      View in: PubMed
    195. Shariat SF, Karam JA, Raman JD. Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects. Biomark Med. 2008 Apr; 2(2):165-80. PMID: 20477438.
      View in: PubMed
    196. Raman JD, Thomas J, Lucas SM, Bensalah K, Lotan Y, Trimmer C, Cadeddu JA. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes. Can J Urol. 2008 Apr; 15(2):3980-5. PMID: 18405445.
      View in: PubMed
    197. Bensalah K, Raman JD, Bagrodia A, Marvin A, Lotan Y. Does obesity impact the costs of partial and radical nephrectomy? J Urol. 2008 May; 179(5):1714-7; discussion 1717-8. PMID: 18343428.
      View in: PubMed
    198. Raman JD, Cadeddu JA, Rao P, Rane A. Single-incision laparoscopic surgery: initial urological experience and comparison with natural-orifice transluminal endoscopic surgery. BJU Int. 2008 Jun; 101(12):1493-6. PMID: 18325059.
      View in: PubMed
    199. Raman JD, Pearle MS. Management options for lower pole renal calculi. Curr Opin Urol. 2008 Mar; 18(2):214-9. PMID: 18303547.
      View in: PubMed
    200. Rosoff JS, Raman JD, Del Pizzo JJ. Laparoscopic adrenalectomy for large adrenal masses. Curr Urol Rep. 2008 Jan; 9(1):73-9. PMID: 18366978.
      View in: PubMed
    201. Kauffman EC, Raman JD. Bladder cancer following upper tract urothelial carcinoma. Expert Rev Anticancer Ther. 2008 Jan; 8(1):75-85. PMID: 18095885.
      View in: PubMed
    202. Raman JD, Bensalah K, Bagrodia A, Stern JM, Cadeddu JA. Laboratory and clinical development of single keyhole umbilical nephrectomy. Urology. 2007 Dec; 70(6):1039-42. PMID: 18158008.
      View in: PubMed
    203. Herman MP, Raman JD, Dong S, Samadi D, Scherr DS. Increasing body mass index negatively impacts outcomes following robotic radical prostatectomy. JSLS. 2007 Oct-Dec; 11(4):438-42. PMID: 18246641; PMCID: PMC3015841.
    204. Wang GJ, Barocas DA, Raman JD, Scherr DS. Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy. BJU Int. 2008 Jan; 101(1):89-93. PMID: 17888044.
      View in: PubMed
    205. Raman JD, Gopalan A, Russo P. Tubulovillous adenoma in an Indiana pouch urinary diversion managed by endoscopic resection. Int J Urol. 2007 Sep; 14(9):865-6. PMID: 17760759.
      View in: PubMed
    206. Raman JD, Scherr DS. Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol. 2007 Aug; 4(8):432-43. PMID: 17673914.
      View in: PubMed
    207. Raman JD, Sosa RE, Vaughan ED, Scherr DS. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Urology. 2007 Feb; 69(2):251-4. PMID: 17320658.
      View in: PubMed
    208. Raman JD, Dong S, Levinson A, Samadi D, Scherr DS. Robotic radical prostatectomy: operative technique, outcomes, and learning curve. JSLS. 2007 Jan-Mar; 11(1):1-7. PMID: 17651548; PMCID: PMC3015817.
    209. Tewari A, Raman JD, Chang P, Rao S, Divine G, Menon M. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Urology. 2006 Dec; 68(6):1268-74. PMID: 17169648.
      View in: PubMed
    210. Rosoff JS, Raman JD, Del Pizzo JJ. Feasibility of laparoscopic approach in management of xanthogranulomatous pyelonephritis. Urology. 2006 Oct; 68(4):711-4. PMID: 17070338.
      View in: PubMed
    211. Raman JD, Palese MA, Ng CK, Boorjian SA, Scherr DS, Del Pizzo JJ, Sosa RE. Hand-assisted laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma. JSLS. 2006 Oct-Dec; 10(4):432-8. PMID: 17575752; PMCID: PMC3015762.
    212. Tewari A, El-Hakim A, Rao S, Raman JD. Identification of the retrotrigonal layer as a key anatomical landmark during robotically assisted radical prostatectomy. BJU Int. 2006 Oct; 98(4):829-32. PMID: 16879447.
      View in: PubMed
    213. Raman JD, Mongan NP, Tickoo SK, Boorjian SA, Scherr DS, Gudas LJ. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res. 2005 Dec 15; 11(24 Pt 1):8570-6. PMID: 16361539.
      View in: PubMed
    214. Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma. Carcinogenesis. 2006 Mar; 27(3):499-507. PMID: 16344273.
      View in: PubMed
    215. Raman JD, Nobert CF, Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol. 2005 Nov; 174(5):1819-22; discussion 1822. PMID: 16217294.
      View in: PubMed
    216. Raman JD, Ng CK, Boorjian SA, Vaughan ED, Sosa RE, Scherr DS. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int. 2005 Nov; 96(7):1031-5. PMID: 16225523.
      View in: PubMed
    217. Raman JD, Walmsley K, Goldstein M. Inheritance of varicoceles. Urology. 2005 Jun; 65(6):1186-9. PMID: 15913726.
      View in: PubMed
    218. Shelton JB, Barocas DA, Conway F, Hart K, Nelson K, Richstone L, Gonzalez RR, Raman JD, Scherr DS. Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies. Urology. 2005 May; 65(5):931-6. PMID: 15882726.
      View in: PubMed
    219. Raman JD, Goldstein M. The presence of vasal vessels in men with congenital bilateral absence of the vas deferens. J Urol. 2004 Nov; 172(5 Pt 1):1941-3. PMID: 15540760.
      View in: PubMed
    220. Raman JD, Goldstein M. Intraoperative characterization of arterial vasculature in spermatic cord. Urology. 2004 Sep; 64(3):561-4. PMID: 15351593.
      View in: PubMed
    221. Raman JD, Schlegel PN. Testicular sperm extraction with intracytoplasmic sperm injection is successful for the treatment of nonobstructive azoospermia associated with cryptorchidism. J Urol. 2003 Oct; 170(4 Pt 1):1287-90. PMID: 14501743.
      View in: PubMed
    222. Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol. 2002 Feb; 167(2 Pt 1):624-9. PMID: 11792932.
      View in: PubMed
    Raman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _